Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.8 SAR
471.20 M SAR
3.21 B SAR
40.52 M
About DALLAH HEALTHCARE CO.
Sector
Industry
CEO
Ahmad bin Saleh Babaeer
Website
Headquarters
Riyadh
Founded
1994
ISIN
SA135G51UI10
FIGI
BBG003H109T1
Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. It invests in hospitals, production of medical supplies, wholesale and retail of medicals, surgical equipment, artificial parts and the operation of healthcare facilities. The firm also manufactures and distributes herbal medicines. The company was founded on September 18, 1994, and is headquartered in Riyadh, Saudi Arabia.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 4004 is 127.8 SAR — it has decreased by −0.16% in the past 24 hours. Watch DALLAH HEALTHCARE CO. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TADAWUL exchange DALLAH HEALTHCARE CO. stocks are traded under the ticker 4004.
4004 stock has risen by 0.16% compared to the previous week, the month change is a 2.76% rise, over the last year DALLAH HEALTHCARE CO. has showed a −23.93% decrease.
We've gathered analysts' opinions on DALLAH HEALTHCARE CO. future price: according to them, 4004 price has a max estimate of 183.00 SAR and a min estimate of 89.30 SAR. Watch 4004 chart and read a more detailed DALLAH HEALTHCARE CO. stock forecast: see what analysts think of DALLAH HEALTHCARE CO. and suggest that you do with its stocks.
4004 reached its all-time high on Feb 26, 2024 with the price of 194.0 SAR, and its all-time low was 26.8 SAR and was reached on Dec 17, 2012. View more price dynamics on 4004 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4004 stock is 1.27% volatile and has beta coefficient of 0.88. Track DALLAH HEALTHCARE CO. stock price on the chart and check out the list of the most volatile stocks — is DALLAH HEALTHCARE CO. there?
Today DALLAH HEALTHCARE CO. has the market capitalization of 12.36 B, it has increased by 5.31% over the last week.
Yes, you can track DALLAH HEALTHCARE CO. financials in yearly and quarterly reports right on TradingView.
DALLAH HEALTHCARE CO. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
4004 earnings for the last quarter are 1.17 SAR per share, whereas the estimation was 1.30 SAR resulting in a −10.34% surprise. The estimated earnings for the next quarter are 1.21 SAR per share. See more details about DALLAH HEALTHCARE CO. earnings.
DALLAH HEALTHCARE CO. revenue for the last quarter amounts to 808.88 M SAR, despite the estimated figure of 905.16 M SAR. In the next quarter, revenue is expected to reach 868.43 M SAR.
4004 net income for the last quarter is 113.90 M SAR, while the quarter before that showed 126.15 M SAR of net income which accounts for −9.71% change. Track more DALLAH HEALTHCARE CO. financial stats to get the full picture.
Yes, 4004 dividends are paid quarterly. The last dividend per share was 0.50 SAR. As of today, Dividend Yield (TTM)% is 1.57%. Tracking DALLAH HEALTHCARE CO. dividends might help you take more informed decisions.
DALLAH HEALTHCARE CO. dividend yield was 1.33% in 2024, and payout ratio reached 41.40%. The year before the numbers were 1.17% and 54.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DALLAH HEALTHCARE CO. EBITDA is 682.54 M SAR, and current EBITDA margin is 21.29%. See more stats in DALLAH HEALTHCARE CO. financial statements.
Like other stocks, 4004 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DALLAH HEALTHCARE CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DALLAH HEALTHCARE CO. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DALLAH HEALTHCARE CO. stock shows the sell signal. See more of DALLAH HEALTHCARE CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.